High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt

The emergence and spread of carbapenem-resistant gram-negative bacteria poses a serious threat to human health worldwide. Currently, little is known about the molecular mechanisms underlying carbapenem resistance and their prevalence among gram-negative bacteria in Egypt. In this study, we analyzed...

Full description

Saved in:
Bibliographic Details
Published in:Microbial drug resistance (Larchmont, N.Y.) Vol. 23; no. 7; p. 838
Main Authors: Khalifa, Hazim O, Soliman, Ahmed M, Ahmed, Ashraf M, Shimamoto, Toshi, Hara, Toshinori, Ikeda, Mitsuyasu, Kuroo, Yuta, Kayama, Shizuo, Sugai, Motoyuki, Shimamoto, Tadashi
Format: Journal Article
Language:English
Published: United States 01-10-2017
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The emergence and spread of carbapenem-resistant gram-negative bacteria poses a serious threat to human health worldwide. Currently, little is known about the molecular mechanisms underlying carbapenem resistance and their prevalence among gram-negative bacteria in Egypt. In this study, we analyzed carbapenemase production in gram-negative bacteria isolated from hospitalized patients in Egypt in 2014. All isolates were subjected to phenotypic and genotypic susceptibility testing for carbapenem resistance. Our results indicated a high level of carbapenem-resistant gram-negative bacteria in Egypt, with 50.8% of the isolates harboring at least one carbapenem resistance gene. OXA-48-like and NDM-1 were the most prevalent carbapenemases, being detected in 49.2%, and 47.7% of carbapenemase-positive isolates, respectively, whereas Verona integron-encoded metallo-β-lactamase (VIM) was detected in only 26.2% of carbapenemase-positive isolates. This study reports for the first time carbapenemase-producing Serratia marcescens, Morganella morganii, and bla -producing Pseudomonas aeruginosa in Egypt. It is also the first demonstration of the coexistence of different carbapenemases, being detected in 21.5% of carbapenemase-positive isolates. Effective antibiotic supervision, regional surveillance, and early detection of carbapenemase producers are imperative to prevent their future spread to epidemic levels.
ISSN:1931-8448
DOI:10.1089/mdr.2015.0339